Methods of inducing T cell activation by administering an antibody comprising CD40 and 4-1BB (CD137) binding domains | Patent Number 10457735

US 10457735 B2
Application Number15538419
Publication NumberUS 20180194849 A1
Pendency3 years, 9 months, 25 days
Filled DateJan 8, 2016
Priority DateJan 8, 2016
Publication DateJul 12, 2018
Expiration DateJan 7, 2036
Inventor/ApplicantsUgur Sahin
David Satijn
Friederike Gieseke
Isil Altintas
Paul Parren
ExaminesLANDSMAN, ROBERT S
Art Unit1647
Technology Center1600
Assignments
Biontech Ag
Current
Genmab As
Original
Biontech Ag
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.